NCT06735456

Brief Summary

This study will be conducted to examine the effect of mandala painting on anxiety, physiological parameters and patient satisfaction in women with breast cancer receiving chemotherapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 24, 2024

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

December 6, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 16, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

July 3, 2025

Status Verified

June 1, 2025

Enrollment Period

1.3 years

First QC Date

December 6, 2024

Last Update Submit

June 30, 2025

Conditions

Keywords

Breast cancerNursingMandala

Outcome Measures

Primary Outcomes (5)

  • Physiological parameter 1

    Temperature

    2 hours (pre-test and post-test)

  • Physiological parameter 2

    Pulse

    2 hours (pre-test and post-test)

  • Physiological parameter 3

    Blood pressure

    2 hours (pre-test and post-test)

  • Physiological parameter 4

    spO2

    2 hours (pre-test and post-test)

  • Physiological parameter 5

    Respiratory rate

    2 hours (pre-test and post-test)

Secondary Outcomes (1)

  • Beck Anxiety Scale

    2 hours (pre-test and post-test)

Study Arms (2)

Mandala Group

EXPERIMENTAL

The patient will undergo mandala painting during 1 session of chemotherapy.

Other: Mandala

Control Group

NO INTERVENTION

No application will be made to this group by the researcher.

Interventions

MandalaOTHER

The patient will undergo mandala painting during 1 session of chemotherapy.

Mandala Group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsSince it is a study conducted on breast cancer women, it concerns the female gender.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being diagnosed with breast cancer,
  • Being receiving adjuvant or neoadjuvant chemotherapy,
  • Being over 18 years of age,
  • Ability to communicate in Turkish,
  • Not having a physical disability related to the upper extremities,
  • Agreeing to participate in the study.

You may not qualify if:

  • Advanced stage cancer patients,
  • Having visual, hearing and speech disabilities,
  • Individuals with mental and neuropsychiatric diseases will not be included in the sample.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sağlık Bilimleri Üniversitesi

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Filiz Ünal Toprak

    Saglik Bilimleri Universitesi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Since the application will be performed by the researcher, patients will be blinded in this study. The statistician will be blinded in the evaluation of the data.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Two groups with a mandala group and control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof. Dr.

Study Record Dates

First Submitted

December 6, 2024

First Posted

December 16, 2024

Study Start

February 24, 2024

Primary Completion

May 30, 2025

Study Completion

June 30, 2025

Last Updated

July 3, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations